A Randomized Comparison of Non-Channeled Glidescope(TM) Titanium Versus Channeled KingVision(TM) Videolaryngoscope for Orotracheal Intubation in Obese Patients with BMI > 35 kg.m(-2)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F20%3A00120959" target="_blank" >RIV/00216224:14110/20:00120959 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/20:10419783 RIV/00064165:_____/20:10419783

Výsledek na webu

<a href="https://www.mdpi.com/2075-4418/10/12/1024" target="_blank" >https://www.mdpi.com/2075-4418/10/12/1024</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/diagnostics10121024" target="_blank" >10.3390/diagnostics10121024</a>

Jazyk výsledku

angličtina

Název v původním jazyce

A Randomized Comparison of Non-Channeled Glidescope(TM) Titanium Versus Channeled KingVision(TM) Videolaryngoscope for Orotracheal Intubation in Obese Patients with BMI > 35 kg.m(-2)

Popis výsledku v původním jazyce

Videolaryngoscopes may improve intubating conditions in obese patients. A total of 110 patients with a body mass index &gt; 35 kg center dot m(-2) were prospectively randomized to tracheal intubation using non-channeled Glidescope Titanium or channeled King Vision videolaryngoscope. The primary outcome was the time to tracheal intubation. Secondary outcomes included: total success rate, number of attempts, the quality of visualization, peri-procedural and post-proceduralcomplications. Time to the first effective breath was shorter with the King Vision (median; 95% CI)-36; 34-39 s vs. 42; 40-50 in the Glidescope group (p = 0.007). The total success rate was higher in the Glidescope group-100% vs. 89.1% (p = 0.03). There was a higher incidence of moderate and difficult laryngoscopy in the King Vision group. No difference was recorded in first attempt success rates, total number of attempts, use of additional maneuvers, intraoperative trauma, or any significant decrease in SpO(2) during intubation. No serious complications were noted and the incidence of postoperative complaints was without difference. Although tracheal intubation with King Vision showed shorter time to the first breath, total success was higher in the Glidescope group, and all but one patients where intubation failed with the KingVision were subsequently intubated with the Glidescope.

Název v anglickém jazyce

A Randomized Comparison of Non-Channeled Glidescope(TM) Titanium Versus Channeled KingVision(TM) Videolaryngoscope for Orotracheal Intubation in Obese Patients with BMI > 35 kg.m(-2)

Popis výsledku anglicky

Videolaryngoscopes may improve intubating conditions in obese patients. A total of 110 patients with a body mass index &gt; 35 kg center dot m(-2) were prospectively randomized to tracheal intubation using non-channeled Glidescope Titanium or channeled King Vision videolaryngoscope. The primary outcome was the time to tracheal intubation. Secondary outcomes included: total success rate, number of attempts, the quality of visualization, peri-procedural and post-proceduralcomplications. Time to the first effective breath was shorter with the King Vision (median; 95% CI)-36; 34-39 s vs. 42; 40-50 in the Glidescope group (p = 0.007). The total success rate was higher in the Glidescope group-100% vs. 89.1% (p = 0.03). There was a higher incidence of moderate and difficult laryngoscopy in the King Vision group. No difference was recorded in first attempt success rates, total number of attempts, use of additional maneuvers, intraoperative trauma, or any significant decrease in SpO(2) during intubation. No serious complications were noted and the incidence of postoperative complaints was without difference. Although tracheal intubation with King Vision showed shorter time to the first breath, total success was higher in the Glidescope group, and all but one patients where intubation failed with the KingVision were subsequently intubated with the Glidescope.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30218 - General and internal medicine

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Diagnostics

ISSN

2075-4418

e-ISSN

2075-4418

Svazek periodika

10

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

11

Strana od-do

1-11

Kód UT WoS článku

000601930500001

EID výsledku v databázi Scopus

2-s2.0-85109085399